BioSpace

Sarepta’s new CEO confident in clinical execution as DMD competitors close in

Sarepta Therapeutics’ newly minted CEO Michael Severino laid out his path to returning the muscular dystrophy therapy maker to the forefront of the rapidly expanding market.

By BioSpace

1 min read
Sarepta’s new CEO confident in clinical execution as DMD competitors close in
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights